131 related articles for article (PubMed ID: 9193581)
1. Humoral mechanism of split tolerance to lymphocyte and heart allografts after donor-specific transfusion.
Jasklowska-Englisz M; Olszewski WL; Maksymowicz M; Poreda E; Ziolkowska A
Transplant Proc; 1997 Jun; 29(4):2185-6. PubMed ID: 9193581
[No Abstract] [Full Text] [Related]
2. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
[TBL] [Abstract][Full Text] [Related]
3. Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2.
Onodera K; Chandraker A; Kato H; Volk HD; Sayegh MH; Kupiec-Weglinski JW
Transplant Proc; 1999; 31(1-2):876-7. PubMed ID: 10083384
[No Abstract] [Full Text] [Related]
4. Abrogation of accelerated allograft rejection by intrathymic injection of donor spleen cells is associated with upregulation of donor-reactive IgM, IgG1, and IgG2A, but depression of IgG2B in the circulation and at the graft site.
Binder J; Hancock WW; Watschinger B; Wasowska B; Sayegh MH; Kupiec-Weglinski JW
Transplant Proc; 1995 Feb; 27(1):138-41. PubMed ID: 7878919
[No Abstract] [Full Text] [Related]
5. Donor-specific transfusion does not mitigate but accelerates rejection of intravenously transplanted lymphocytes.
Jaskłowska-Englisz M; Podgórska D; Adamczyk G; Olszewski WL
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):365-71. PubMed ID: 8010878
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of accelerated rejection of intravenously transplanted allogeneic lymphocytes by donor-specific transfusion-treated rats.
Olszewski WL; Jasklowska-Englisz M; Adamczyk G
Transplant Proc; 1992 Dec; 24(6):3000-1. PubMed ID: 1466033
[No Abstract] [Full Text] [Related]
7. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
Schmidbauer G; Hancock WW; Wasowska B; Binder J; Padberg W; Kupiec-Weglinski JW
Transplant Proc; 1995 Feb; 27(1):427-9. PubMed ID: 7879048
[No Abstract] [Full Text] [Related]
8. Induction of antigen-specific tolerance: antigen form and injection route.
Yoshimura N; Hamashima T; Oka T
Transplant Proc; 1996 Jun; 28(3):1150-1. PubMed ID: 8658604
[No Abstract] [Full Text] [Related]
9. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047
[No Abstract] [Full Text] [Related]
10. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism.
Shirwan H; Wang HK; Barwari L; Makowka L; Cramer DV
Transplantation; 1996 May; 61(9):1382-6. PubMed ID: 8629301
[TBL] [Abstract][Full Text] [Related]
11. The different influences of allosensitization and xenosensitization on cellular rejection.
Fryer JP; Chen S; Johnson EM; Sun LH; Matas AJ
Transplant Proc; 1996 Apr; 28(2):674. PubMed ID: 8623338
[No Abstract] [Full Text] [Related]
12. Donor treatment prolongs survival of rat cardiac allografts in sensitized rat recipients.
Schmidbauer G; Kuenzel JS; Homeyer A; Schwemmle K
Transplant Proc; 2002 Nov; 34(7):2897-8. PubMed ID: 12431650
[No Abstract] [Full Text] [Related]
13. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
Schmidbauer G; Homeyer A; Bohle RM; Grimm H; Binder J; Kupiec-Weglinski JW
Transplant Proc; 1997; 29(1-2):607-8. PubMed ID: 9123151
[No Abstract] [Full Text] [Related]
14. Donor-specific transfusion in the nude rat prolongs survival of subsequently transplanted hamster cardiac xenografts.
Valdivia LA; Sun H; Rao AS; Tsugita M; Chen CT; Park IY; Fung JJ; Starzl TE
Transplant Proc; 1997; 29(1-2):928-9. PubMed ID: 9123590
[No Abstract] [Full Text] [Related]
15. Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity.
Korom S; De Meester I; Schmidbauer G; Pratschke J; Brendel MD; Durinx C; Schwemmle K; Haemers A; Scharpé S; Kupiec-Weglinski JW
Transplant Proc; 1999; 31(1-2):778. PubMed ID: 10083329
[No Abstract] [Full Text] [Related]
16. Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected.
Jaskłowska-Englisz M; Olszewski WL
Transplant Proc; 1994 Dec; 26(6):3463. PubMed ID: 7998224
[No Abstract] [Full Text] [Related]
17. High interleukin-12 p40 mRNA expression in tolerant heart allografts in recipient rats treated by donor-specific transfusion.
Cuturi MC; Heslan JM; Josien R; Douillard P; Soulillou JP
Transplant Proc; 1997; 29(1-2):1170. PubMed ID: 9123258
[No Abstract] [Full Text] [Related]
18. Tolerance induction to cardiac allografts by sequential intrathymic inoculation of disparate alloantigens.
Shimomura K; Hardy MA; Oluwole SF
Transplant Proc; 1996 Jun; 28(3):1283-4. PubMed ID: 8658661
[No Abstract] [Full Text] [Related]
19. Modulation of acute and hyperacute rejection of xenografts in concordant hamster-to-rat combination.
Sablinski T; Hancock WW; Wasowska BA; Schmidbauer G; Baldwin WM; Kut JP; Milford EL; Kupiec-Weglinski JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):432-4. PubMed ID: 8438366
[No Abstract] [Full Text] [Related]
20. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.
Motoyama K; Lehmann M; Flye MW
Transplant Proc; 1999; 31(1-2):1237-8. PubMed ID: 10083552
[No Abstract] [Full Text] [Related]
[Next] [New Search]
